Annual Cash & Cash Equivalents
$2.21 M
-$7.91 M-78.17%
December 31, 2023
Summary
- As of February 7, 2025, BJDX annual cash & cash equivalents is $2.21 million, with the most recent change of -$7.91 million (-78.17%) on December 31, 2023.
- During the last 3 years, BJDX annual cash & cash equivalents has risen by +$1.30 million (+142.05%).
- BJDX annual cash & cash equivalents is now -88.41% below its all-time high of $19.05 million, reached on December 31, 2021.
Performance
BJDX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$5.76 M
-$2.30 M-28.58%
September 30, 2024
Summary
- As of February 7, 2025, BJDX quarterly cash and cash equivalents is $5.76 million, with the most recent change of -$2.30 million (-28.58%) on September 30, 2024.
- Over the past year, BJDX quarterly cash and cash equivalents has increased by +$3.55 million (+160.62%).
- BJDX quarterly cash and cash equivalents is now -69.78% below its all-time high of $19.05 million, reached on December 31, 2021.
Performance
BJDX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BJDX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -78.2% | +160.6% |
| 3 y3 years | +142.1% | -56.7% |
| 5 y5 years | +2200.5% | -56.7% |
BJDX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.4% | at low | -69.8% | +160.6% |
| 5 y | 5-year | -88.4% | +2200.5% | -69.8% | +530.8% |
| alltime | all time | -88.4% | +2200.5% | -69.8% | +530.8% |
Bluejay Diagnostics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.76 M(-28.6%) |
| Jun 2024 | - | $8.06 M(+202.8%) |
| Mar 2024 | - | $2.66 M(+20.5%) |
| Dec 2023 | $2.21 M(-78.2%) | $2.21 M(-56.5%) |
| Sep 2023 | - | $5.08 M(-0.5%) |
| Jun 2023 | - | $5.10 M(-24.8%) |
| Mar 2023 | - | $6.78 M(-33.0%) |
| Dec 2022 | $10.12 M | $10.12 M(-23.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $13.29 M(-13.4%) |
| Jun 2022 | - | $15.34 M(-10.4%) |
| Mar 2022 | - | $17.12 M(-10.1%) |
| Dec 2021 | $19.05 M(+1987.7%) | $19.05 M(+717.5%) |
| Sep 2021 | - | $2.33 M(-2.9%) |
| Jun 2021 | - | $2.40 M(+163.1%) |
| Dec 2020 | $912.40 K(+850.4%) | $912.40 K |
| Dec 2019 | $96.00 K | - |
FAQ
- What is Bluejay Diagnostics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bluejay Diagnostics?
- What is Bluejay Diagnostics annual cash & cash equivalents year-on-year change?
- What is Bluejay Diagnostics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bluejay Diagnostics?
- What is Bluejay Diagnostics quarterly cash and cash equivalents year-on-year change?
What is Bluejay Diagnostics annual cash & cash equivalents?
The current annual cash & cash equivalents of BJDX is $2.21 M
What is the all time high annual cash & cash equivalents for Bluejay Diagnostics?
Bluejay Diagnostics all-time high annual cash & cash equivalents is $19.05 M
What is Bluejay Diagnostics annual cash & cash equivalents year-on-year change?
Over the past year, BJDX annual cash & cash equivalents has changed by -$7.91 M (-78.17%)
What is Bluejay Diagnostics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BJDX is $5.76 M
What is the all time high quarterly cash and cash equivalents for Bluejay Diagnostics?
Bluejay Diagnostics all-time high quarterly cash and cash equivalents is $19.05 M
What is Bluejay Diagnostics quarterly cash and cash equivalents year-on-year change?
Over the past year, BJDX quarterly cash and cash equivalents has changed by +$3.55 M (+160.62%)